Menu

Investors

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
May 16, 2022
Document Date
May 12, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Akebia Therapeutics
Issuer
Akebia Therapeutics, Inc.
Filer
COTREAU VIOLETTA
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us